Epirubicin hydrochloride

盐酸表柔比星

Also known as: Epirubicin HCl, Ellence, Pharmorubicin, epi-Doxorubicin HCl, Epirubicin Ebewe, 4'-epidoxorubicin hydrochloride, Pidorubicin hydrochloride

Epirubicin hydrochloride (CAS 56390-09-1) is a compound in the Organic Acids category listed in the Jingsj chemical database. It has the molecular formula C27H30ClNO11 and a molecular weight of 579.980 g/mol. It is also known as Epirubicin HCl, Ellence and Pharmorubicin. Key properties include a melting point of 185ºC dec, a boiling point of 810.3ºC at 760 mmHg, a density of 1.61g/cm3 and a flash point of 443.8ºC. It is classified under GHS with signal word Danger and hazard statements H302 — Harmful if swallowed, H340 and H350 — May cause cancer. No supplier offers are currently listed; request a quote. Record last updated Aug 21, 2026.

CAS No.: 56390-09-1
Jingsj CID: J-31616-7
Molecular Formula: C₂₇H₃₀ClNO₁₁
Chinese Name: 盐酸表柔比星
Molecular Weight: 579.980 g/mol
Category: Organic Acids
Last updated: 8/21/2026

No offers for this compound yet.

Request a quote

Physicochemical Properties

Melting Point	185ºC dec
Boiling Point	810.3ºC at 760 mmHg
Density	1.61g/cm3
Flash Point	443.8ºC
Exact Mass	579.150757
PSA	206.07000
LogP	1.50360
Refractive Index	1.709

GHS Safety & Compliance

Irritant / Health HazardSignal word: Danger

H302 — Harmful if swallowed
H340
H350 — May cause cancer
H360 — May damage fertility or the unborn child

Activity & Biological Data

Target	Topoisomerase
Additional Information	[1]. Cersosimo RJ, et al. Epirubicin: a review of the pharmacology, clinical activity, and adverse effects of an adriamycin analogue. J Clin Oncol. 1986 Mar;4(3):425-39. [2]. Ozkan, A., et al. Epirubicin HCl toxicity in human-liver derived hepatoma G2 cells. Pol J Pharmacol, 2004. 56(4): p. 435-44. [3]. Bonadonna, G., et al. Drugs ten years later: epirubicin. Ann Oncol, 1993. 4(5): p. 359-69. [4]. Asanuma, F., et al. Antitumor activity of paclitaxel and epirubicin in human breast carcinoma, R-27. Folia Microbiol (Praha), 1998. 43(5): p. 473-4.

Target

Topoisomerase

Additional Information

[1]. Cersosimo RJ, et al. Epirubicin: a review of the pharmacology, clinical activity, and adverse effects of an adriamycin analogue. J Clin Oncol. 1986 Mar;4(3):425-39. [2]. Ozkan, A., et al. Epirubicin HCl toxicity in human-liver derived hepatoma G2 cells. Pol J Pharmacol, 2004. 56(4): p. 435-44. [3]. Bonadonna, G., et al. Drugs ten years later: epirubicin. Ann Oncol, 1993. 4(5): p. 359-69. [4]. Asanuma, F., et al. Antitumor activity of paclitaxel and epirubicin in human breast carcinoma, R-27. Folia Microbiol (Praha), 1998. 43(5): p. 473-4.

Customs & Trade Information

HS Code	2932999099
Summary	2932999099. other heterocyclic compounds with oxygen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%

Frequently Asked Questions

What is the CAS number of Epirubicin hydrochloride?

The CAS number of Epirubicin hydrochloride is 56390-09-1.

What are the molecular formula and molecular weight of Epirubicin hydrochloride?

Epirubicin hydrochloride has molecular formula C27H30ClNO11 and molecular weight 579.980 g/mol.

Is Epirubicin hydrochloride hazardous?

Epirubicin hydrochloride has GHS signal word Danger and hazard statements H302 — Harmful if swallowed; H340; H350 — May cause cancer.

Data compiled from public chemical databases and supplier catalogs; supplier offers are provided by suppliers.

Last updated: 8/21/2026

How to cite: Jingsj. "Epirubicin hydrochloride (CAS 56390-09-1)". Jingsj Chemical Database. https://www.jingsj.com/compound/J-31616-7 (accessed 2026-10-28).

Data for reference only; verify specifications, grades and regulatory status with suppliers before purchase.